CYTOR and breast cancer: NEAT1 has been shown to be involved in many cancers [53,54], and promotes chemoresistance in TNBC [17], while early studies on the lncRNA CYTOR (also known as LINC00152) have shown it may regulate signalling in breast cancers [55,56].